Aurora Spine Corporation to present at Lytham Partners

CARLSBAD, Calif., Sep. 30, 2021 (GLOBE NEWSWIRE) – Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spine surgery results, today announced its attendance at the Lytham Partners Fall 2021 Investor Conference October 5-7. Aurora President and CEO Trent Northcutt will make the presentation to the company’s investors on Tuesday, October 5, 2021 at 2:45 p.m. ET.

A webcast of the presentation will be available on the Company’s website at or The webcast will be archived and available for replay following the live event.

Mr. Northcutt and Mr. Chad Clouse, CFO of Aurora Spine, will also be available for one-on-one meetings throughout the event, which is scheduled for October 5-7. To arrange a meeting, please contact Lytham Partners at 1×[email protected] or register by clicking here.

“I am delighted to participate in the Lytham Partners Investor Lecture Series again, where I will update existing investors and share Aurora’s story with potential investors. We have an exciting history and believe we are on the road to success coming out of Covid. We have worked diligently to convert many of our third-party products into proprietary products while continuing to develop new products. Several new products should be marketed in the coming quarters. I look forward to discussing Aurora’s growth strategy with investors, ”said Mr. Northcutt.

About Aurora Spine

Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive and regenerative spinal implant technologies. Additional information is available at or

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

This press release contains forward-looking information that involves known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under “Risk Factors” and “Caution Regarding Forward-Looking Information” in Aurora Spine’s final prospectus (collectively, “forward-looking information”). The forward-looking information contained in this press release includes information regarding the proposed use and success of Aurora Spine’s products. company in surgical procedures Aurora Spine cautions investors in Aurora Spine securities of important factors that could cause Aurora Spine’s actual results to differ materially from those projected in the forward-looking statements included in this release press release. Any statement that expresses or involves discussions regarding expectations, beliefs nces, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties that could lead to actual results or results. differ unilaterally from those expressed in these forward-looking statements. No assurance can be given that the expectations set forth herein will prove to be correct and, therefore, potential investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine assumes no obligation to update or revise them to reflect new events or circumstances.


Aurora Spine Corporation

Trent Northcutt
President and CEO
(760) 424-2004

Chad Clouse
Financial director
(760) 424-2004

Adam lowensteiner
Phoenix | new York
Telephone: 646-829-9700
[email protected]

Comments are closed.